• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, October 29, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Optimized Media and Flow Cytometry Track Mycoplasma hyopneumoniae Growth in Real Time

by
October 29, 2026
in Biology
Reading Time: 3 mins read
0
Optimized Media and Flow Cytometry Track Mycoplasma hyopneumoniae Growth in Real Time

Optimized Media and Flow Cytometry Track Mycoplasma hyopneumoniae Growth in Real Time

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Mycoplasma hyopneumoniae, the primary etiologic agent of swine enzootic pneumonia, is notoriously difficult to grow in the laboratory and in industrial settings. A study published in AMB Express on 2 October 2026 reports a practical attempt to ease that bottleneck, combining newly formulated culture media with a real-time growth monitoring platform for the CJ strain of the bacterium.

The researchers, led by Liangkun Zhang, Shuhong Gao, Kexin Xu and Li Chen, note that industrial production of the pathogen is severely constrained by its intrinsically slow growth, its fastidious nutrient demands, and the lack of robust real-time cell count quantification. Those constraints matter because vaccines remain the cornerstone of disease control, and vaccine manufacturing depends on reliable, scalable cultivation of the organism.

Conventional methods have added to the difficulty. The color change unit assay, a standard approach for quantifying mycoplasmas, requires 14 days of incubation, exhibits poor reproducibility, and precludes dynamic optimization of cultivation processes. In other words, producers have had little ability to adjust culture conditions while a batch is still running.

To address these problems, the team formulated two optimized Friis-based media, designated CL6 and GD-240.

The second major contribution is a dynamic monitoring platform that integrates a logistic growth model with flow cytometry. This combination was developed to enable real-time tracking of mycoplasma growth, replacing the need to wait days for a color change endpoint. From the platform, the researchers defined five key growth parameters that characterize how the organism behaves in each medium.

Kinetic profiling of the two formulations showed measurable differences. GD-240 increased maximum cell counts by 17.5 percent compared with the alternative, and it prolonged the rapid growth phase by 2.7 hours. Both figures come from the study’s model-based analysis of growth dynamics rather than from a single endpoint measurement, reflecting the continuous monitoring the platform makes possible.

Beyond cell counts, the study used quantitative PCR to clarify the temporal expression patterns of core metabolic and virulence genes during growth. As one example, the researchers found that deoB and ldh were upregulated at 30 hours and downregulated at 42 hours. This kind of time-resolved gene expression data offers a window into the physiology of the organism as it moves through different growth phases in a given medium.

The authors state that these practical methodological approaches were provided for the optimization of mycoplasma cultivation and dynamic physiological analysis. The work is presented as a methods-oriented contribution: it does not report vaccine efficacy or clinical outcomes, but rather tools and measurements intended to make cultivation of this slow-growing pathogen more controllable and better understood.

For researchers and manufacturers working with M. hyopneumoniae, the reported combination of optimized media, flow cytometry-based counting, and qPCR-based expression profiling offers a faster and more informative way to compare culture conditions than the traditional 14-day color change assay. The article, published as an open-access paper in AMB Express, is currently available as an accepted manuscript that is citable and carries a permanent DOI, with a final version of record to follow.

Subject of Research: Optimization of culture media and real-time growth monitoring for Mycoplasma hyopneumoniae

Article Title: Growth dynamic curve and gene expression analysis for optimized culture medium of Mycoplasma hyopneumoniae CJ strain

Article References: Zhang, L., Gao, S., Xu, K., & Chen, L. (2026). Growth dynamic curve and gene expression analysis for optimized culture medium of Mycoplasma hyopneumoniae CJ strain. AMB Express. https://doi.org/10.1186/s13568-026-02123-4

Image Credits: AI Generated

DOI: 10.1186/s13568-026-02123-4

Keywords: Mycoplasma hyopneumoniae, swine enzootic pneumonia, culture medium, flow cytometry, logistic growth model, qPCR, gene expression, Friis medium, vaccine production, microbiology, Growth, dynamic

News Source: Juliet Wilcox. (October 29, 2026). Optimized Media and Flow Cytometry Track Mycoplasma hyopneumoniae Growth in Real Time. Scienmag.

Tags: culture mediumDynamicflow cytometryFriis mediumgene expressiongrowthlogistic growth modelMicrobiologyMycoplasma hyopneumoniaeqPCRswine enzootic pneumoniavaccine production
Share12Tweet7Share2ShareShareShare1

Related Posts

Iranian Cat Coronavirus Isolates Are Type I, Spike Mutation Study Finds

Iranian Cat Coronavirus Isolates Are Type I, Spike Mutation Study Finds

October 29, 2026
Periplocin Kills Osteosarcoma Cells by Driving Necroptosis and Pyroptosis

Periplocin Kills Osteosarcoma Cells by Driving Necroptosis and Pyroptosis

October 29, 2026

China-wide surveillance finds streptococcal resistance varies by species and breakpoint choice

October 29, 2026

Bacteria-Grown Iron Oxide Nanoparticles Curb Biofilms and Boost Antibiotics

October 29, 2026

POPULAR NEWS

  • One Camera, Four Sensors: AI Tracks Warehouse Packages in Real Time

    One Camera, Four Sensors: AI Tracks Warehouse Packages in Real Time

    29 shares
    Share 12 Tweet 7
  • Cellular Stress Protein JWA Emerges as Context-Dependent Redox Hub in Aging and Disease

    29 shares
    Share 12 Tweet 7
  • AI lectures fall short of human teaching in urology residency trial

    29 shares
    Share 12 Tweet 7
  • New daisy relative discovered on Mount Everest’s slopes named after Zhufeng

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Chronic Kidney Disease Affects Nearly 15% of Fulni-ô Indigenous Adults in Brazil

Iranian Cat Coronavirus Isolates Are Type I, Spike Mutation Study Finds

Periplocin Kills Osteosarcoma Cells by Driving Necroptosis and Pyroptosis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.